02:25 PM EDT, 03/14/2024 (MT Newswires) -- Century Therapeutics ( IPSC ) shares fell 7.4% in recent Thursday trading after the company reported a wider loss and lower revenue in 2023.

The company reported a full-year loss of $2.30 per diluted share, compared with the loss of $2.27 a year earlier.

Collaboration revenue in the year ended Dec. 31 fell to $2.24 million from $5.2 million a year earlier, the company said Thursday.

As of Dec. 31, the company reported $261.8 million in cash, cash equivalents and marketable securities, and that's expected to support operations into 2026.

Price: 4.50, Change: -0.36, Percent Change: -7.41